ACRO BIOMEDICAL CO., LTD. (ACBM) stock: key figures, P/E, revenue and dividend
Communication Services · United States · ISIN US0048921052
ACRO BIOMEDICAL CO., LTD. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -154,024.00 USD |
| EBIT | -101,146.00 USD |
| Net income | -101,146.00 USD |
| Diluted EPS – continuing operations | 0.00 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ACRO BIOMEDICAL CO., LTD.
Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
More stocks
- Emmaus Life Sciences, Inc. (EMMA)
- Invech Holdings, Inc. (IVHI)
- ARTELO BIOSCIENCES, INC. (ARTL)
- ModuLink Inc. (MDLK)
- Boxlight Corp (BOXL)
- Solaris Energy Infrastructure, Inc. (SEI)
- SENTIENT BRANDS HOLDINGS INC. (SNBH)
- TOFUTTI BRANDS INC (TOFB)
- iSpecimen Inc. (ISPC)
- PROCYON CORP (PCYN)
- SILVER BULL RESOURCES, INC. (SVBL)
- Tego Cyber, Inc. (TGCB)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.